Dr Pooyeh Farahmand
- Research Associate (CRUK Scotland Institute)
email:
Pooyeh.Farahmand@gla.systa-s.com
Garscube State, Switchback Road, Bearsden, Glasgow, G61 1BD
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Pooyeh.Farahmand@gla.systa-s.com
Garscube State, Switchback Road, Bearsden, Glasgow, G61 1BD
Rovers, S. et al. (2025) A minimally invasive transthoracic injection technique for reproducible intrapleural delivery in mice. Methods and Protocols, 8(3), 55. (doi: 10.3390/mps8030055) (PMID:40559443) (PMCID:PMC12195961)
Chrisochoidou, Y. et al. (2023) Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease, 14(11), 725. (doi: 10.1038/s41419-023-06240-x) (PMID:37938546) (PMCID:PMC10632403)
Farahmand, P. et al. (2023) Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Frontiers in Toxicology, 5, 1200650. (doi: 10.3389/ftox.2023.1200650) (PMID:37441092) (PMCID:PMC10333928)
Marini, A. et al. (2021) The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nature Communications, 12, 4920. (doi: 10.1038/s41467-021-25173-7) (PMID:34389715) (PMCID:PMC8363647)
Rovers, S. et al. (2025) A minimally invasive transthoracic injection technique for reproducible intrapleural delivery in mice. Methods and Protocols, 8(3), 55. (doi: 10.3390/mps8030055) (PMID:40559443) (PMCID:PMC12195961)
Chrisochoidou, Y. et al. (2023) Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease, 14(11), 725. (doi: 10.1038/s41419-023-06240-x) (PMID:37938546) (PMCID:PMC10632403)
Farahmand, P. et al. (2023) Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Frontiers in Toxicology, 5, 1200650. (doi: 10.3389/ftox.2023.1200650) (PMID:37441092) (PMCID:PMC10333928)
Marini, A. et al. (2021) The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nature Communications, 12, 4920. (doi: 10.1038/s41467-021-25173-7) (PMID:34389715) (PMCID:PMC8363647)